NCT04304768View on ClinicalTrials.gov

Opioid, HIV and Immune System

PHASE4RecruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

November 18, 2020

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2026

Conditions

Immune Defect

Interventions

BIOLOGICAL

Fluzone Quadrivalent

0.5 ml prefilled syringe administrated intramuscularly

Trial Locations (1)

33136

RECRUITING

University of Miami, Miami

All Listed Sponsors

lead

University of Miami

OTHER